In APP/PS1 mice, lower EAAT2 levels around plaques lead to extrasynaptic glutamate accumulation and neuronal hyperactivity (Hefendehl et al., 2016), though human AD brain analyses suggest astrocytic resilience (Kobayashi et al., 2018). Here, APP is linked to Alzheimer disease.